SDPD Finds a Way Around State Law Limiting DNA Collection From Juveniles
By Kelly Davis,
Voice of San Diego
| 02. 15. 2017
When it comes to collecting DNA from criminal offenders, California law is especially protective of juveniles.
While 2004’s Proposition 69 broadened police authority to collect DNA without a warrant, it put limits on when DNA can be collected from juveniles. Only if a youth has been found guilty of a felony or required to register as a sex offender can law enforcement obtain a DNA sample.
But the San Diego Police Department has found a way around state law. The department maintains its own database — one that’s not linked to state or federal DNA databases. According to department policy, as long as a DNA profile remains in the local database, officers can collect DNA from anyone for “investigative purposes.” The policy requires only that officers get a signed consent from the minor. It doesn’t require them to notify the minor’s parent or guardian until after the sample’s been taken.
A lawsuit filed Tuesday by the ACLU of San Diego and Imperial Counties challenges that policy, and argues that a juvenile is incapable of providing informed consent, especially if he...
Related Articles
By Emily Baumgaertner Nunn, The New York Times | 06.11.2026
When scientists at Columbia University announced they had used a newer technology to precisely edit the genes of human embryos last week, they set the academic community ablaze with debate. Is this good news or bad? How fast will...
By Gina Kolata, The New York Times | 06.11.2026
On my second visit with Nancy Wexler at her Manhattan apartment, she had a gift for me. It was a copy of her newly published memoir, “My Life, My Science: Pursuing a Cure for Huntington’s Disease.”
It had been signed...
By Samuelle Fajutrao Falk , The Conversation | 06.26.2026
When my colleagues and I asked autistic people and parents of autistic children in Sweden how they feel about genetic research in autism, one response stood out: “I hope genetic research finds new ways to help us, not erase us.”...
By Rebecca Simkin, BioNews | 06.29.2026
The US Food and Drug Administration (FDA) is allowing biotech company Regenxbio to reapply for licensing of a gene therapy for Hunter syndrome, in a reversal of its previous decision. Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a...